Leading Companies in Thailand Metoprolol Market | Insights & Key Players 2026

Thailand Metoprolol Market Overview

According to 6Wresearch, the Thailand metoprolol market is maintaining a steady growth trajectory, supported by the national Universal Health Coverage (UHC) scheme and an aging population with increased cardiovascular needs. Furthermore, as Thai manufacturers achieve higher levels of PIC/S GMP compliance, the sector is expanding its reach into the broader ASEAN region, specifically targeting the CLMV markets. Innovations in extended-release formulations and increased tablet stability are improving patient compliance and treatment outcomes.

Competitive Landscape

The competitive landscape of the Thailand metoprolol market is defined by strategic competition between global pharmaceutical innovators and private domestic leaders. Success in this sector is dictated by a company's ability to secure inclusion in the National List of Essential Medicines (NLEM), which facilitates large-scale hospital supply, while also building trust through branded generic recognition in retail pharmacies.

Below is a list of leading players operating in the Thailand Metoprolol Market:

1. Pfizer Inc.

A global research-based pharmaceutical giant that provides high-standard cardiovascular therapies and maintains a significant clinical presence in Thailand's premium hospital sector.

2. Novartis AG

A world leader in cardiovascular medicine, providing innovative and high-fidelity beta-blocker formulations that set the benchmark for clinical efficacy in the Thai market.

3. Viatris Inc.

Formed through the merger of Mylan and Pfizer's Upjohn, Viatris leverages a massive global portfolio to provide high-quality cardiovascular and non-communicable disease (NCD) treatments across Thailand.

4. Sun Pharmaceutical Industries Ltd.

The world's fourth-largest specialty generic pharmaceutical company, operating in Thailand as Ranbaxy (Thailand) Co. Ltd. for over 30 years, providing a wide range of affordable and high-quality cardiovascular treatments.

5. Biolab Co., Ltd.

Specialized in sophisticated manufacturing processes, Biolab provides high-quality metoprolol tartrate and succinate formulations for both domestic and export use.

6. Cipla Inc.

A global pharmaceutical leader focused on making healthcare accessible; Cipla provides an extensive portfolio of cardiovascular medicines and anti-hypertensives designed to improve patient outcomes in emerging markets.

7. Aurobindo Pharma

A vertically integrated global powerhouse and one of the world's largest manufacturers of generic metoprolol API and finished dosages, supplying high-volume cardiovascular portfolios to over 150 countries.

8. Teva Pharmaceutical Industries Ltd.

The world's leading generic drug manufacturer, Teva maintains a strong presence in the Thai market, offering a vast array of high-quality cardiovascular and specialty medicines through its local subsidiary in Bangkok.

9. Olic (Thailand) Limited

As a leading contract manufacturing organization (CMO), Olic produces high-quality metoprolol and other critical drugs for major multinational firms.

10. AstraZeneca

Maintains a significant presence in the premium segment as the originator of various beta-blocker innovations used in advanced cardiac treatment.

11. Hikma Pharmaceuticals PLC

A major multinational pharmaceutical group specializing in high-quality generic and in-licensed injectable and oral medicines, significantly contributing to the cardiovascular supply chain in emerging pharmaceutical markets.